Research on amyotrophic lateral sclerosis (ALS) is ongoing, with various institutions and organizations reporting progress in clinical trials and treatment development. Some outlets suggest that new therapies and treatments may be able to slow disease progression, improve strength and mobility, or even stop the illness. The field appears to be advancing, with new discoveries, emerging therapies, and clinical trials underway, but the extent of the progress and its potential impact on patients is not yet clear.